Invivyd to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor Conference
Invivyd (NASDAQ: IVVD) has announced its participation in the H.C. Wainwright 3rd Annual BioConnect Investor Conference. The company's management will engage in a fireside chat on Tuesday, May 20, 2025, at 11:00 a.m. ET in New York. Management will also be available for investor meetings during the conference.
Interested investors attending the conference can arrange meetings through their H.C. Wainwright representative. The fireside chat will be accessible via live webcast on the company's investor relations website at investors.invivyd.com and will remain available for approximately 30 days after the presentation.
Invivyd (NASDAQ: IVVD) ha annunciato la sua partecipazione alla 3ª Conferenza Annuale BioConnect per Investitori di H.C. Wainwright. Il management dell'azienda parteciperà a una tavola rotonda informale il martedì 20 maggio 2025 alle 11:00 ET a New York. Il team dirigenziale sarà inoltre disponibile per incontri con gli investitori durante la conferenza.
Gli investitori interessati a partecipare possono organizzare incontri tramite il loro rappresentante H.C. Wainwright. La tavola rotonda sarà trasmessa in diretta streaming sul sito web delle relazioni con gli investitori dell'azienda all'indirizzo investors.invivyd.com e resterà disponibile per circa 30 giorni dopo la presentazione.
Invivyd (NASDAQ: IVVD) ha anunciado su participación en la 3ª Conferencia Anual BioConnect para Inversores de H.C. Wainwright. La dirección de la empresa participará en una charla informal el martes 20 de mayo de 2025 a las 11:00 a.m. ET en Nueva York. Además, la dirección estará disponible para reuniones con inversores durante la conferencia.
Los inversores interesados en asistir pueden coordinar reuniones a través de su representante de H.C. Wainwright. La charla informal será accesible mediante una transmisión en vivo en el sitio web de relaciones con inversores de la compañía en investors.invivyd.com y estará disponible aproximadamente 30 días después de la presentación.
Invivyd (NASDAQ: IVVD)가 H.C. Wainwright 제3회 연례 BioConnect 투자자 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 2025년 5월 20일 화요일 오전 11시(동부시간) 뉴욕에서 진행되는 소규모 대화에 참여할 예정입니다. 또한 경영진은 컨퍼런스 기간 동안 투자자 미팅에도 참석할 예정입니다.
컨퍼런스에 참석하는 관심 있는 투자자들은 H.C. Wainwright 담당자를 통해 미팅을 예약할 수 있습니다. 소규모 대화는 회사 투자자 관계 웹사이트 investors.invivyd.com에서 생중계되며, 발표 후 약 30일 동안 다시 시청할 수 있습니다.
Invivyd (NASDAQ : IVVD) a annoncé sa participation à la 3e conférence annuelle BioConnect pour investisseurs de H.C. Wainwright. La direction de l'entreprise participera à une discussion informelle le mardi 20 mai 2025 à 11h00 (heure de l'Est) à New York. La direction sera également disponible pour des réunions avec les investisseurs durant la conférence.
Les investisseurs intéressés présents à la conférence peuvent organiser des rencontres via leur représentant H.C. Wainwright. La discussion informelle sera accessible en direct via un webcast sur le site des relations investisseurs de l'entreprise à l'adresse investors.invivyd.com et restera disponible environ 30 jours après la présentation.
Invivyd (NASDAQ: IVVD) hat seine Teilnahme an der 3. jährlichen BioConnect Investorenkonferenz von H.C. Wainwright angekündigt. Das Management des Unternehmens wird am Dienstag, den 20. Mai 2025, um 11:00 Uhr ET in New York an einem Gespräch am Kamin teilnehmen. Das Management steht während der Konferenz auch für Investorenmeetings zur Verfügung.
Interessierte Investoren, die an der Konferenz teilnehmen, können Meetings über ihren H.C. Wainwright Vertreter arrangieren. Das Gespräch am Kamin wird live über die Investor-Relations-Website des Unternehmens unter investors.invivyd.com übertragen und bleibt etwa 30 Tage nach der Präsentation verfügbar.
- None.
- None.
WALTHAM, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that management will participate in a fireside chat at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on Tuesday, May 20, 2025, at 11:00 a.m. ET in New York, NY.
In addition to the fireside chat, the management team will host investor meetings at the conference. Investors participating in the conference who are interested in meeting with Invivyd management should contact their H.C. Wainwright representative.
A live webcast of the fireside chat will be available in the investor section of the company's website at investors.invivyd.com and will be archived for approximately 30 days following the presentation.
About Invivyd
Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more.
Contacts:
Media Relations
(781) 208-1747
media@invivyd.com
Investor Relations
(781) 208-1747
investors@invivyd.com
FAQ
When is Invivyd (IVVD) presenting at the H.C. Wainwright BioConnect Conference 2025?
How can investors access Invivyd's presentation at the H.C. Wainwright Conference?
How can investors schedule meetings with Invivyd management at the H.C. Wainwright Conference?
How long will Invivyd's H.C. Wainwright Conference presentation be available for replay?
